PLUS Products (PLUS.C) and CannRX Biosciences are working to perfect your cannabis 2.0 experience

PLUS Products (PLUS.C) partnered with Israeli-based CannRx Biosciences today to enhance and improve-upon the onset time for their gummies and other cannabis-infused products, according to a press release.

CannRx has a research lab in Tel Aviv, Israel where they created a solid nano-particle water soluble technology (CannTrap) using proteins to enhance cannabinoid bioavailability and terpenes.

“We are excited about the relationship with CannRx and their research team, and the opportunity to further advance the science behind our products. Israel leads the way in cannabis research and the industry is ripe for innovation. We believe that consumers want to take control of how quickly they can feel the effects of cannabis. Our goal is to put them in the driver’s seat for the experience, from start to finish,” said Jake Heimark, CEO and co-founder of PLUS.

To put together and test their technology, CannRx replicated the body’s natural protein-based transport system, which moves active compounds through the body, and tailored the process for cannabinoids. PLUS and CannRx intends to use the patented CannTrap technology to make products with a more controlled onset and offset times, so consumers can have more control over their own experience. The idea is that PLUS wants to spread these formulations across their portfolio, while reducing the dose needed and increasing the onset speed.

The optimal condition for taking edibles like PLUS’s gummies and other products like beverages, would be to come home after a hard day and take a few gummies. Within a half hour, you’re relaxed but not enough to become one with the couch. After another hour or so, you ease out of it but maintain the low-grade chill while you make dinner.

CannRx is spearheaded by Dr. William Levine, founder and chief scientific officer, who was selected as Cannabis and Tech Today’s Innovator of the Year in 2019.

“PLUS is committed to quality and innovation,” said Dr. Levine. “The CannRx team is excited about our partnership with PLUS and we look forward to bringing innovative, high quality products to the cannabis market.”

PLUS Products is a long-time equity guru client that’s been around and selling their award winning gummies and candies in California before cannabis 2.0 was even an idea in Canada. They’re headquartered in San Mateo, California. Meanwhile, CannRx Biosciences, whose stated mission is the development of scientifically-based cannabis technologies, intends to streamline your cannabis edible experience to make it more reliable, repeatable and efficient.